Enke JS, Gross M, Grosser B, Sipos E, et al. SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer. BMC Cancer 2024;24:65.
PMID: 38216952